Add Row

Add Element

update

Pulse On Wellcare

update

Add Element

Home
Categories
Events
Healthy Aging

October 28.2025

2 Minutes Read

Syngene International Strengthens Governance with Surender Sharma as General Counsel

Syngene International executive smiling in front of corporate building

Syngene's New Legal Leadership: Meet Surender Sharma

Bengaluru-based Syngene International has recently fortified its executive team with the appointment of Surender Sharma as General Counsel and member of the Executive Committee. Effective from October 28, 2025, Sharma steps into this key role with an impressive repertoire of experience, signaling a solid strategy for corporate governance amidst a rapidly evolving legal landscape.

A Wealth of Experience in Corporate Governance

Sharma arrives at Syngene after a successful tenure at Colgate-Palmolive (India) Limited, where he served as the Whole-Time Director and Vice President for various legal capacities. With over two decades spanning significant firms like Marico, Heinz, and Indian Hotels, his experience encompasses crucial areas of corporate governance including mergers and acquisitions, compliance, and joint ventures.

Educational Background: A Solid Foundation

Surender Sharma's academic credentials are as impressive as his professional journey. Holding a Bachelor of Science in Chemistry from St. Stephen’s College and an LLB from Delhi University, he also boasts qualifications as a Company Secretary. This multi-disciplinary foundation enhances his capability to navigate complex regulatory frameworks effectively.

Shaping Syngene’s Future

As Syngene continues to navigate the dynamic landscape of the pharmaceutical sector, Sharma’s leadership is positioned to be pivotal. His expertise in corporate ethics and sustainability frameworks will prove invaluable as the company strives to maintain compliance while driving innovative solutions in contract research and manufacturing.

Surender Sharma's Vision for Syngene

Sharma's vision for his new role includes strengthening the legal framework of Syngene International to align with industry trends and address emerging challenges. This proactive approach aims to ensure that the company remains not only compliant but also a leader in ethical practices within the healthcare sector.

Conclusion: A Strategic Move Towards Growth

The appointment of Surender Sharma marks a significant milestone for Syngene International. His comprehensive knowledge and expertise not only enhance the company’s legal prowess but also instill confidence in stakeholders looking for robust governance and ethical practices. As the firm expands its capabilities and navigates complex legal landscapes, Sharma's leadership will undoubtedly play a vital role in shaping Syngene's future.

Telemedicine Access

Write A Comment

Related Posts All Posts

11.18.2025

Infant Abduction in Kolkata: How Rapid Response Saved a Life

Update Shocking Incident Leading to a Heroic Rescue In a distressing episode that took place on November 18, 2025, a six-month-old infant was abducted from the Dr. BC Roy Post Graduate Institute of Paediatric Sciences in Kolkata. The mother, an 18-year-old from Uttar Kashipur, had visited the hospital for treatment when she unknowingly handed her baby to a woman posing as a helpful nurse. This deceiving act of kindness led to a frantic hours-long search that ultimately concluded with the infant's safe recovery. Community Response and the Power of Collaboration The incident highlights the collaborative efforts of local law enforcement which began immediately after the abduction was reported. Police officers relied on 26 CCTV feeds to trace the woman's movements as she fled the hospital with the infant. Scenes captured at various locations led investigators to piece together her path, describing how the woman was spotted with the child in nearby areas, allowing them to close in on her location quickly. A Reminder of Dangers in Public Spaces This incident sheds light on the vulnerabilities faced by parents in crowded settings such as hospitals. According to Dilip Pal, the principal of the hospital, ensuring the safety of children amidst numerous visitors poses a significant challenge. Hospital authorities are now considering increased security measures and public awareness announcements to deter such tragic events in the future. “We encourage mothers and guardians to not hand their children over to strangers, no matter the situation,” Pal remarked, emphasizing the critical need for caution. Emotional Toll and Community Support For the baby's mother, this ordeal was deeply traumatic. The emotional toll of handing over her child to someone she believed was trustworthy is unimaginable. Survivors of such incidents often face lingering fear and anxiety, making community support crucial. Local engagement and conversation about safety can empower families to remain vigilant and aware in communal environments. Impact on Healthcare Protocols As hospitals strive to provide optimal care, the unexpected fallout from this situation has sparked discussions about possible changes in healthcare protocols. Enhanced training for staff and the implementation of stricter guidelines regarding patient interaction could serve to protect vulnerable patients. Hospitals may also look into incorporating telemedicine options to reduce the need for in-person visits, especially for consultations that do not require physical examinations. Taking Action to Prevent Future Abductions The swift resolution of this case offers a glimmer of hope amid a disturbing trend. With community vigilance and proactive measures, it is possible to safeguard our families. Everyone has a role to play—from hospital staff to parents on the ground—by reporting suspicious behavior and maintaining a secure environment for all. In conclusion, this incident has not only reinvigorated discussions on safety in public spaces but has also demonstrated the rapid response efforts of law enforcement and community members alike. The safe recovery of the infant stands testament to what can be achieved when a community bands together for a common cause.

11.17.2025

Marksans Pharma Expands UK Reach with Mefenamic Acid Tablets Approval

Update Marksans Pharma’s Significant Milestone in the UK Market Marksans Pharma, a name increasingly recognized in the pharmaceutical sector, recently achieved a notable feat with its UK arm receiving marketing authorization from the MHRA for Mefenamic Acid film-coated tablets. This accomplishment encompasses two formulations, 250 mg and 500 mg, aimed at expanding the company's reach in the competitive UK market. Breaking Down Mefenamic Acid's Importance Mefenamic Acid is a widely used non-steroidal anti-inflammatory drug (NSAID) effective for treating mild to moderate pain, including menstrual cramps and other inflammatory conditions. Its inclusion in Marksans Pharma's portfolio enhances their analgesic offerings, making pain relief more accessible and affordable to the UK population. This approval not only strengthens the product lineup but also illustrates the company’s ongoing commitment to address health needs effectively. Strategic Implications for Marksans Pharma The regulatory green light by the UK Medicines and Healthcare products Regulatory Agency (MHRA) not only positions Marksans Pharma favorably against competitors but also opens doors for additional growth in a highly regulated market. As countries continue to elevate their healthcare standards, having products approved by such a reputable agency signals credibility and reliability, enhancing customer trust. Broader Impact on Global Health Initiatives This recent approval is part of a larger trend where pharmaceutical companies are diversifying their portfolios to address global health challenges. As Marksans Pharma further enhances its market presence in the UK, it aligns with broader initiatives that aim to improve healthcare accessibility worldwide. This is especially vital in a post-pandemic landscape where the demand for effective medications is critical. The Community Perspective: Why This Matters At its core, this achievement goes beyond just numbers on a balance sheet; it's about real-world implications for patients. By introducing essential medications like Mefenamic Acid to the market, Marksans Pharma contributes to the community's overall wellness. Improved access to pain management options can significantly enhance the quality of life for many individuals, particularly those suffering from chronic conditions. Looking Ahead: A Vision for Continued Growth As Marksans Pharma solidifies its place in the UK pharmaceutical landscape, it also sets the stage for future innovations. The strategy to expand its product portfolio reflects a vision not just for immediate gains but for long-term health improvement initiatives. It is this forward-thinking approach that inspires community confidence and fuels ongoing interest in the company's growth story. In summary, the authorization of Mefenamic Acid film-coated tablets by Marksans Pharma is a significant step forward for both the company and its stakeholders, marking a pivotal moment in enhancing healthcare access in the UK.

11.16.2025

Establishing Chest Clinics to Combat Pollution-Related Diseases

Update Chest Clinics: A Vital Response to Air Pollution Health Crisis The Indian government is stepping up its fight against air pollution-related health issues by establishing specialized "chest clinics" across the nation. This initiative, prompted by increasing air quality concerns, aims to provide targeted healthcare services in areas most affected by environmental pollutants. Primarily focused on cities identified under the National Clean Air Programme (NCAP), these clinics will aid in screening patients afflicted by pulmonary and cardiovascular diseases exacerbated by pollution. Why Chest Clinics Are Essential Now Recent statistics from health experts have indicated a staggering estimate of 1.7 million deaths annually in India due to air pollution, emphasizing an urgent requirement for accessible healthcare solutions. The Ministry of Health and Family Welfare mandated these chest clinics operate for at least two hours daily during peak pollution periods, ensuring that individuals receive timely medical assistance. In line with directives, states are encouraged to facilitate Out-Patient Departments (OPDs) within these clinics that focus on respiratory medicine, providing necessary medications and resources. Enhanced training for medical personnel will be crucial to handle the influx of patients facing complications taken root by polluted air. Addressing Unique Needs of Vulnerable Populations Particularly, vulnerable groups including children, the elderly, and individuals with pre-existing respiratory issues will benefit from these specialized services. The clinics aim to not only treat but also educate patients about the causes of their ailments and promote lifestyle changes that could minimize health risks associated with pollution. With frequent public health advisories being issued regarding the dangers of high AQI levels, this initiative represents a proactive approach to managing and mitigating health crises. The Role of Telemedicine in Enhancing Reach As part of a broader strategy to combat the health effects of pollution, integrating telemedicine into these chest clinics can expand access to care. By allowing remote consultations, patients from marginalized communities can gain access to medical advice without the barriers of travel or transportation. This modern approach can significantly improve the healthcare landscape in areas heavily impacted by pollution. Local and Global Perspectives on Air Quality Experts argue that while India’s response is critical, global cooperation and understanding of air quality issues are equally necessary. Pollution does not recognize borders, and solutions must extend beyond national initiatives. Learning from regions that successfully tackled air pollution could offer valuable insights and methods to implement effective policies in India. Future Predictions for Urban Health Initiatives As India grapples with its air quality crisis, establishing chest clinics is just the beginning. The need for continuous evaluation and improvement of public health policies, along with community awareness programs about pollution, will shape the future of urban health. The balance between economic development and environmental health remains a critical conversation as the nation progresses toward a healthier future. Conclusion The establishment of chest clinics is a significant and essential step in combating the dire health effects of pollution in India. By addressing air pollution-related diseases through accessible healthcare, public health infrastructures can improve community resilience. Everyone, from government bodies to individuals, plays a part in safeguarding our environment and health.